Sionc Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 12.58 Cr
as on 16-11-2024
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 133.51 Cr
as on 16-11-2024
- Satisfied Charges ₹ 59.73 Cr
as on 16-11-2024
- Revenue 23.68%
(FY 2023)
- Profit 66.34%
(FY 2023)
- Ebitda 46.49%
(FY 2023)
- Net Worth 22.39%
(FY 2023)
- Total Assets 29.68%
(FY 2023)
About Sionc Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 12.58 Cr.
The company currently has active open charges totaling ₹133.51 Cr. The company has closed loans amounting to ₹59.73 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sionc Pharmaceuticals Private Limited India is Suman Lahoti as COMPANY SECRETARY. Baburao Dandamudi, Jagadeesh Rangisetty, Manikreddy Pullagurla, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232AP2008PTC057417
- Company No.
057417
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sionc Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Baburao Dandamudi  | Managing Director | 01-Feb-2008 | Current |
| Suman Lahoti | Company Secretary | 01-Feb-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jagadeesh Rangisetty | Director | 01-Feb-2008 | Current |
| Manikreddy Pullagurla | Director | 21-May-2009 | Current |
| Srikanth Dandamudi | Director | 21-May-2009 | Current |
| Subba Jetti | Director | 01-Dec-2011 | Current |
Financial Performance and Corporate Structure Insights of Sionc Pharmaceuticals.
Sionc Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.68% increase. The company also saw a substantial improvement in profitability, with a 66.34% increase in profit. The company's net worth Soared by an impressive increase of 22.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sionc Pharmaceuticals?
In 2023, Sionc Pharmaceuticals had a promoter holding of 37.91% and a public holding of 62.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Azico Biophore India Private LimitedActive 16 years 1 monthJagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
Leiutis Pharmaceuticals LlpActive 3 years 7 monthsJagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
Biophore India Pharmaceuticals Private LimitedActive 17 years 8 monthsJagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
- Zenara Pharma Private LimitedActive 20 years 9 months
Jagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
- Alithia Pharmaceuticals Private LimitedActive 3 years 5 months
Jagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Sep 2024 | ₹30.00 Cr | Open |
Hdfc Bank Limited Creation Date: 14 Mar 2023 | ₹2.97 M | Open |
Hdfc Bank Limited Creation Date: 25 Nov 2022 | ₹3.35 M | Open |
How Many Employees Work at Sionc Pharmaceuticals?
Sionc Pharmaceuticals has a workforce of 324 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sionc Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sionc Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
